Jr. Robert E. Funck - 28 Feb 2022 Form 4 Insider Report for ABBOTT LABORATORIES (ABT)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
02 Mar 2022, 18:44:35 UTC
Prior SEC filing
23 Feb 2022
Next SEC filing
22 Feb 2023
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Robert E. Funck, Jr. by Jessica H. Paik, Attorney-in-Fact

Key filing fact

Jr. Robert E. Funck filed Form 4 for ABBOTT LABORATORIES (ABT) on 02 Mar 2022.

Key facts

  • This page summarizes Jr. Robert E. Funck's Form 4 filing for ABBOTT LABORATORIES (ABT).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 02 Mar 2022, 18:44.

Change

  • Previous filing in this sequence was filed on 23 Feb 2022.
  • Current net transaction value: -$1,315,908.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ABT transaction

Common shares without par value

Tax liability

Transaction value
$1,315,908
Shares
-10,750
Change %
-4.9%
Price
$122.41
Shares after
206,582
Date
28 Feb 2022
Ownership
Direct
ABT holding

Common shares without par value

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
10,000
Date
28 Feb 2022
Ownership
By Trust
Footnotes
F1
ABT holding

Common shares without par value

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
10,000
Date
28 Feb 2022
Ownership
By Trust
Footnotes
F1
ABT holding

Common shares without par value

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
18,085
Date
28 Feb 2022
Ownership
Profit Sharing Trust
Footnotes
F2
ABT holding

Common shares without par value

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
500
Date
28 Feb 2022
Ownership
By Daughter
Footnotes
F3
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

Held in daughter's annual gift trust. The reporting person disclaims beneficial ownership of all securities held by the trust.

Footnote F2

Balance in the Abbott Laboratories Stock Retirement Trust as of February 28, 2022.

Footnote F3

The reporting person disclaims beneficial ownership of all securities held by his daughter.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .